curaplex Epi Safe Administration and Training Kits, #8600-01100, Contains: 2 Epi Safe Administrat...
FDA Drug Recall #D-0383-2019 — Class II — November 2, 2018
Recall Summary
| Recall Number | D-0383-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 2, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Bound Tree Medical, LLC |
| Location | Dallas, TX |
| Product Type | Drugs |
| Quantity | 1,283 kits (8 syringes per kit / 3 IFU's per kit) |
Product Description
curaplex Epi Safe Administration and Training Kits, #8600-01100, Contains: 2 Epi Safe Administration Kit (8600-01101), 1 Epi Safe Training Kit (8600-01102), Rx Only, Distributed by Sarnova HC, LLC s family of companies: Bound Tree Medical, LLC, Cardio Partners, Inc., Emergency Medical Products, Inc. & Tri-anim Health Services, Inc. 5000 Tuttle Crossing Blvd. Dublin, OH 43016
Reason for Recall
Labeling Incorrect Instructions: This recall has been initiated because the Instructions for Use included in the Epi-Safe Kits for the Epi-Safe Syringe (and/or the Safety Lok Syringe in Model 8600-01120) recommend a midpoint dosage of epinephrine for children between 0 lbs. and 66 lbs. of 0.15mL that has not been approved by FDA for children. Reliance on the current IFU and/or use of the Epi-Safe Syringe as instructed may result in the administration of an inappropriate dosage of epinephrine to young children experiencing anaphylaxis, especially those under 33 lbs. Additionally the Epi Safe syringe does not have the correct markings to allow a health care provider to draw up the correct dosage for children under 33 kg.
Distribution Pattern
Nationwide in the USA
Lot / Code Information
all lot numbers
Other Recalls from Bound Tree Medical, LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0386-2019 | Class II | Curaplex Epi Kit NOT FOR IV USE, #8600-01120, E... | Nov 2, 2018 |
| D-0385-2019 | Class II | Curaplex Epi Safe Kit, 8600-01102 TRAINING ONLY... | Nov 2, 2018 |
| D-0384-2019 | Class II | curaplex Epi Safe Kit, 8600-01101, contains:" ... | Nov 2, 2018 |
| D-0371-2019 | Class II | curaplex Epi Safe Administration and Training K... | Nov 1, 2018 |
| D-0379-2019 | Class III | Curaplex Epi Safe Kit, Rx Only, contains: 1mL V... | Nov 1, 2018 |
Frequently Asked Questions
Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.